Toggle menu

Nicky Freeman

Senior Research Nurse

Research Interests:
Global Health Inequalities
Nicky Freeman

Nicola has had a circuitous journey into the role of Research Nurse with EMERGE. An initial interest in research and global inequalities was sparked whilst studying Geography at the University of Glasgow. This led to her undertaking a Masters of Research degree in Human Geography in 2011. Upon graduating Nicola has worked in various capacities in the field of International Development. It was working on a health project in rural Uganda that provided the catalyst for Nicola seeking a more ‘hands on’ role and better understanding of tropical diseases. Nicola has subsequently retrained as nurse at the University of Southampton and completed a Diploma in Tropical Nursing in 2018.

 

After nearly 3 years of working in acute medicine at the University Hospital of Wales, Cardiff, Nicola joined the Emergency Department in Edinburgh. Finding herself increasingly thinking about how patient care might be improved past the day to day, Nicola decided to undertake a research project for her Masters in Nursing. Working in the Royal Infirmary ED, it wasn’t long before Nicola became aware of EMERGE and was immediately captivated. Nicola is very excited to join this dynamic team and have the opportunity to contribute to pragmatic, pioneering research that improves patient care.  

 


Trials

REACT Study

A performance evaluation study designed to assess the precision and accuracy of the Lumira DX point of care (POC) and C-Reactive (CRP) assay as an aid in the detection and evaluation of infection, tissue injury and inflammatory disorders.

In the emergency department (ED), CRP is tested in patients presenting with a variety of symptoms as an aid the detection and evaluation of infection, tissue injury or inflammatory disorders.

Primary objective - To determine the performance of the LumiraDx POC CRP assay when compared to the Siemens Dimension reference method in patients with symptoms of infection, tissue injury and inflammatory disorders.

Sample size - 50 participants over a duration of approximately 4 weeks.

Read more

REACT Study

EMBOL1 Study

A Performance Evaluation of The Lumiradx Point of Care D Dimer Assay AS AN Aid in the Diagnosis and Assessment of VTE (EMBOL1)

NOVEL Study

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more

NOVEL Study

Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions

SABER Study

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)

Read more

SABER Study

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)